The Point-of-Care Glucose Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for point-of-care glucose testing has been experiencing consistent growth. It is projected to increase from $4.91 billion in 2024 to $5.15 billion in 2025, representing a compound annual growth rate (CAGR) of 4.9%.
The Point-of-Care Glucose Testing Global Market is expected to reach $6.51 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.0%.
Download Your Free Sample of the 2025 Point-of-Care Glucose Testing Market Report and Uncover Key Trends Now!The key drivers in the point-of-care glucose testing market are:
• Expansion of telemedicine services
• Growing focus on personalized medicine in diabetes care
• Rise in diabetes management programs
• Increased investment in glucose testing research and development
The point-of-care glucose testing market covered in this report is segmented –
1) By Product: Lancet And Lancing Devices, Strips, Meters
2) By Testing Site: Fingertips, Alternate Site Testing
3) By Applications: Type-1 Diabetes, Type-2 Diabetes
4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users
The key trends in the point-of-care glucose testing market are:
• Development and utilization of wearable glucose monitoring devices are on the rise.
• Integration of smartphone connectivity is becoming a major trend in glucose testing.
• The growth of point-of-care testing is evident in home healthcare settings.
• Adoption of artificial intelligence for glucose data analysis is becoming increasingly popular, along with the expansion of remote patient monitoring for diabetes.
The major players in the point-of-care glucose testing market are:
• F Hoffmann La Roche Ltd
North America was the largest region in the point-of-care glucose testing market in 2024